Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities

Leukemia. 2009 Mar;23(3):617-9. doi: 10.1038/leu.2008.252. Epub 2008 Oct 2.
No abstract available

Publication types

  • Comparative Study
  • Evaluation Study
  • Letter

MeSH terms

  • B-Lymphocytes / pathology*
  • Cell Division / drug effects
  • Cells, Cultured / drug effects
  • Cells, Cultured / ultrastructure
  • Chromosome Aberrations
  • Chromosome Banding / methods
  • Cohort Studies
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Interleukin-2 / pharmacology*
  • Karyotyping / methods*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Lymphocyte Activation / drug effects*
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / pathology
  • Lymphoproliferative Disorders / genetics
  • Lymphoproliferative Disorders / pathology*
  • Male
  • Metaphase
  • Mitogens / pharmacology*
  • Oligonucleotides / pharmacology*
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • CpG-ODN DSP30
  • Interleukin-2
  • Mitogens
  • Oligonucleotides
  • Tetradecanoylphorbol Acetate